A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.

Can a robot help prepare cancer medication in a hospital pharmacy? That's what hospital pharmacist Tjerk Geersing ...

A new drug combination from Corcept Therapeutics, relacorilant, has shown potential in treating platinum-resistant ovarian ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...

The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the ...

Polymer-coated nanoparticles loaded with therapeutic drugs show significant promise for cancer treatment, including ovarian ...

Takeda's Adcetris has become the first drug recommended for routine NHS use as a treatment for previously untreated ...

The Pine Bluff Police Department is now investigating multiple pharmacy burglaries, including one where thieves took a ...

To advance this research towards commercialization, Daniel Fologea benefits from an NSF Transform grant for marketed oriented ...